£18.5M
Leo Cancer Care secures £18.5m in Series B funding led by Pureland Global Venture to advance upright radiotherapy solutions.

Pureland Global Venture led the Series B financing round to support the commercialisation of upright treatment technology.
"We founded Leo Cancer Care to revolutionize the Radiation Therapy space and achieving those sorts of goals only happens when you have incredible partners. Pureland Ventures has been amazing on this journey so far, so it is fantastic to have them lead this Series B financing round. It’s really exciting to see such a great balance of institutional and industry investments, it shows that the industry really shares in our vision for driving change."